[(2R,4R,5R,6S)-3-acetyloxy-4,5-dimethyl-6-[[17-methyl-21-[2-(methylamino)ethyl]-20-oxo-5,7-dioxa-11,21-diazapentacyclo[11.8.0.02,10.04,8.014,19]henicosa-1(13),2,4(8),9,11,14(19),15,17-octaen-16-yl]oxy]oxan-2-yl]methyl acetate;[(2S,3R,4S,5R,6R)-6-ethyl-4,5-dimethyl-2-[[15-methyl-20-(3-morpholin-4-ylpropyl)-11,19-dioxo-5,7-dioxa-20-azapentacyclo[10.8.0.02,10.04,8.013,18]icosa-2,4(8),9,13(18),14,16-hexaen-16-yl]oxy]oxan-3-yl] acetate;[(2S,3S,4R,5S,6S)-2-[[20-(3-imidazol-1-ylpropyl)-15-methyl-11,19-dioxo-5,7-dioxa-20-azapentacyclo[10.8.0.02,10.04,8.013,18]icosa-2,4(8),9,13(18),14,16-hexaen-16-yl]oxy]-4,5,6-trimethyloxan-3-yl] acetate;[(2S,4S,5S,6S)-6-[[20-(3-imidazol-1-ylpropyl)-16-methyl-11,19-dioxo-5,7-dioxa-20-azapentacyclo[10.8.0.02,10.04,8.013,18]icosa-2,4(8),9,13(18),14,16-hexaen-15-yl]oxy]-2,4,5-trimethyloxan-3-yl] acetate;[(2S,4S,5S,6S)-2,4,5-trimethyl-6-[[17-methyl-21-[2-(methylamino)ethyl]-20-oxo-5,7-dioxa-11,21-diazapentacyclo[11.8.0.02,10.04,8.014,19]henicosa-1(13),2,4(8),9,11,14(19),15,17-octaen-16-yl]oxy]oxan-3-yl] acetate
C168H190N14O41 — CID 157420242
Data last refreshed: (MolForge compound catalog, from PubChem)
About [(2R,4R,5R,6S)-3-acetyloxy-4,5-dimethyl-6-[[17-methyl-21-[2-(methylamino)ethyl]-20-oxo-5,7-dioxa-11,21-diazapentacyclo[11.8.0.02,10.04,8.014,19]henicosa-1(13),2,4(8),9,11,14(19),15,17-octaen-16-yl]oxy]oxan-2-yl]methyl acetate;[(2S,3R,4S,5R,6R)-6-ethyl-4,5-dimethyl-2-[[15-methyl-20-(3-morpholin-4-ylpropyl)-11,19-dioxo-5,7-dioxa-20-azapentacyclo[10.8.0.02,10.04,8.013,18]icosa-2,4(8),9,13(18),14,16-hexaen-16-yl]oxy]oxan-3-yl] acetate;[(2S,3S,4R,5S,6S)-2-[[20-(3-imidazol-1-ylpropyl)-15-methyl-11,19-dioxo-5,7-dioxa-20-azapentacyclo[10.8.0.02,10.04,8.013,18]icosa-2,4(8),9,13(18),14,16-hexaen-16-yl]oxy]-4,5,6-trimethyloxan-3-yl] acetate;[(2S,4S,5S,6S)-6-[[20-(3-imidazol-1-ylpropyl)-16-methyl-11,19-dioxo-5,7-dioxa-20-azapentacyclo[10.8.0.02,10.04,8.013,18]icosa-2,4(8),9,13(18),14,16-hexaen-15-yl]oxy]-2,4,5-trimethyloxan-3-yl] acetate;[(2S,4S,5S,6S)-2,4,5-trimethyl-6-[[17-methyl-21-[2-(methylamino)ethyl]-20-oxo-5,7-dioxa-11,21-diazapentacyclo[11.8.0.02,10.04,8.014,19]henicosa-1(13),2,4(8),9,11,14(19),15,17-octaen-16-yl]oxy]oxan-3-yl] acetate
[(2R,4R,5R,6S)-3-acetyloxy-4,5-dimethyl-6-[[17-methyl-21-[2-(methylamino)ethyl]-20-oxo-5,7-dioxa-11,21-diazapentacyclo[11.8.0.02,10.04,8.014,19]henicosa-1(13),2,4(8),9,11,14(19),15,17-octaen-16-yl]oxy]oxan-2-yl]methyl acetate;[(2S,3R,4S,5R,6R)-6-ethyl-4,5-dimethyl-2-[[15-methyl-20-(3-morpholin-4-ylpropyl)-11,19-dioxo-5,7-dioxa-20-azapentacyclo[10.8.0.02,10.04,8.013,18]icosa-2,4(8),9,13(18),14,16-hexaen-16-yl]oxy]oxan-3-yl] acetate;[(2S,3S,4R,5S,6S)-2-[[20-(3-imidazol-1-ylpropyl)-15-methyl-11,19-dioxo-5,7-dioxa-20-azapentacyclo[10.8.0.02,10.04,8.013,18]icosa-2,4(8),9,13(18),14,16-hexaen-16-yl]oxy]-4,5,6-trimethyloxan-3-yl] acetate;[(2S,4S,5S,6S)-6-[[20-(3-imidazol-1-ylpropyl)-16-methyl-11,19-dioxo-5,7-dioxa-20-azapentacyclo[10.8.0.02,10.04,8.013,18]icosa-2,4(8),9,13(18),14,16-hexaen-15-yl]oxy]-2,4,5-trimethyloxan-3-yl] acetate;[(2S,4S,5S,6S)-2,4,5-trimethyl-6-[[17-methyl-21-[2-(methylamino)ethyl]-20-oxo-5,7-dioxa-11,21-diazapentacyclo[11.8.0.02,10.04,8.014,19]henicosa-1(13),2,4(8),9,11,14(19),15,17-octaen-16-yl]oxy]oxan-3-yl] acetate (PubChem CID 157420242) has the molecular formula C168H190N14O41 and a molecular weight of 3061.42 g/mol. Its IUPAC name is [(2R,4R,5R,6S)-3-acetyloxy-4,5-dimethyl-6-[[17-methyl-21-[2-(methylamino)ethyl]-20-oxo-5,7-dioxa-11,21-diazapentacyclo[11.8.0.02,10.04,8.014,19]henicosa-1(13),2,4(8),9,11,14(19),15,17-octaen-16-yl]oxy]oxan-2-yl]methyl acetate;[(2S,3R,4S,5R,6R)-6-ethyl-4,5-dimethyl-2-[[15-methyl-20-(3-morpholin-4-ylpropyl)-11,19-dioxo-5,7-dioxa-20-azapentacyclo[10.8.0.02,10.04,8.013,18]icosa-2,4(8),9,13(18),14,16-hexaen-16-yl]oxy]oxan-3-yl] acetate;[(2S,3S,4R,5S,6S)-2-[[20-(3-imidazol-1-ylpropyl)-15-methyl-11,19-dioxo-5,7-dioxa-20-azapentacyclo[10.8.0.02,10.04,8.013,18]icosa-2,4(8),9,13(18),14,16-hexaen-16-yl]oxy]-4,5,6-trimethyloxan-3-yl] acetate;[(2S,4S,5S,6S)-6-[[20-(3-imidazol-1-ylpropyl)-16-methyl-11,19-dioxo-5,7-dioxa-20-azapentacyclo[10.8.0.02,10.04,8.013,18]icosa-2,4(8),9,13(18),14,16-hexaen-15-yl]oxy]-2,4,5-trimethyloxan-3-yl] acetate;[(2S,4S,5S,6S)-2,4,5-trimethyl-6-[[17-methyl-21-[2-(methylamino)ethyl]-20-oxo-5,7-dioxa-11,21-diazapentacyclo[11.8.0.02,10.04,8.014,19]henicosa-1(13),2,4(8),9,11,14(19),15,17-octaen-16-yl]oxy]oxan-3-yl] acetate.
Molecular Properties
| Compound Name | [(2R,4R,5R,6S)-3-acetyloxy-4,5-dimethyl-6-[[17-methyl-21-[2-(methylamino)ethyl]-20-oxo-5,7-dioxa-11,21-diazapentacyclo[11.8.0.02,10.04,8.014,19]henicosa-1(13),2,4(8),9,11,14(19),15,17-octaen-16-yl]oxy]oxan-2-yl]methyl acetate;[(2S,3R,4S,5R,6R)-6-ethyl-4,5-dimethyl-2-[[15-methyl-20-(3-morpholin-4-ylpropyl)-11,19-dioxo-5,7-dioxa-20-azapentacyclo[10.8.0.02,10.04,8.013,18]icosa-2,4(8),9,13(18),14,16-hexaen-16-yl]oxy]oxan-3-yl] acetate;[(2S,3S,4R,5S,6S)-2-[[20-(3-imidazol-1-ylpropyl)-15-methyl-11,19-dioxo-5,7-dioxa-20-azapentacyclo[10.8.0.02,10.04,8.013,18]icosa-2,4(8),9,13(18),14,16-hexaen-16-yl]oxy]-4,5,6-trimethyloxan-3-yl] acetate;[(2S,4S,5S,6S)-6-[[20-(3-imidazol-1-ylpropyl)-16-methyl-11,19-dioxo-5,7-dioxa-20-azapentacyclo[10.8.0.02,10.04,8.013,18]icosa-2,4(8),9,13(18),14,16-hexaen-15-yl]oxy]-2,4,5-trimethyloxan-3-yl] acetate;[(2S,4S,5S,6S)-2,4,5-trimethyl-6-[[17-methyl-21-[2-(methylamino)ethyl]-20-oxo-5,7-dioxa-11,21-diazapentacyclo[11.8.0.02,10.04,8.014,19]henicosa-1(13),2,4(8),9,11,14(19),15,17-octaen-16-yl]oxy]oxan-3-yl] acetate |
|---|---|
| PubChem CID | 157420242 |
| Molecular Formula | C168H190N14O41 |
| Molecular Weight | 3061.42 g/mol |
| Exact Mass | 3059.32 |
| IUPAC Name | [(2R,4R,5R,6S)-3-acetyloxy-4,5-dimethyl-6-[[17-methyl-21-[2-(methylamino)ethyl]-20-oxo-5,7-dioxa-11,21-diazapentacyclo[11.8.0.02,10.04,8.014,19]henicosa-1(13),2,4(8),9,11,14(19),15,17-octaen-16-yl]oxy]oxan-2-yl]methyl acetate;[(2S,3R,4S,5R,6R)-6-ethyl-4,5-dimethyl-2-[[15-methyl-20-(3-morpholin-4-ylpropyl)-11,19-dioxo-5,7-dioxa-20-azapentacyclo[10.8.0.02,10.04,8.013,18]icosa-2,4(8),9,13(18),14,16-hexaen-16-yl]oxy]oxan-3-yl] acetate;[(2S,3S,4R,5S,6S)-2-[[20-(3-imidazol-1-ylpropyl)-15-methyl-11,19-dioxo-5,7-dioxa-20-azapentacyclo[10.8.0.02,10.04,8.013,18]icosa-2,4(8),9,13(18),14,16-hexaen-16-yl]oxy]-4,5,6-trimethyloxan-3-yl] acetate;[(2S,4S,5S,6S)-6-[[20-(3-imidazol-1-ylpropyl)-16-methyl-11,19-dioxo-5,7-dioxa-20-azapentacyclo[10.8.0.02,10.04,8.013,18]icosa-2,4(8),9,13(18),14,16-hexaen-15-yl]oxy]-2,4,5-trimethyloxan-3-yl] acetate;[(2S,4S,5S,6S)-2,4,5-trimethyl-6-[[17-methyl-21-[2-(methylamino)ethyl]-20-oxo-5,7-dioxa-11,21-diazapentacyclo[11.8.0.02,10.04,8.014,19]henicosa-1(13),2,4(8),9,11,14(19),15,17-octaen-16-yl]oxy]oxan-3-yl] acetate |
| SMILES | CC(=O)OC1[C@H](C)O[C@@H](Oc2cc3c(cc2C)C(=O)N(CCCn2ccnc2)C2c4cc5c(cc4C(=O)C32)OCO5)[C@@H](C)[C@@H]1C.CC(=O)O[C@@H]1[C@H](Oc2cc3c(cc2C)C2C(=O)c4cc5c(cc4C2N(CCCn2ccnc2)C3=O)OCO5)O[C@@H](C)[C@@H](C)[C@H]1C.CC[C@H]1O[C@@H](Oc2cc3c(cc2C)C2C(=O)c4cc5c(cc4C2N(CCCN2CCOCC2)C3=O)OCO5)[C@H](OC(C)=O)[C@@H](C)[C@H]1C.CNCCn1c(=O)c2cc(C)c(O[C@@H]3O[C@@H](C)C(OC(C)=O)[C@@H](C)[C@@H]3C)cc2c2cnc3cc4c(cc3c21)OCO4.CNCCn1c(=O)c2cc(C)c(O[C@@H]3O[C@H](COC(C)=O)C(OC(C)=O)[C@H](C)[C@H]3C)cc2c2cnc3cc4c(cc3c21)OCO4 |
| InChI | InChI=1S/C36H44N2O9.2C34H37N3O8.C33H37N3O9.C31H35N3O7/c1-6-27-20(3)21(4)34(45-22(5)39)36(46-27)47-28-17-26-23(14-19(28)2)31-32(24-15-29-30(44-18-43-29)16-25(24)33(31)40)38(35(26)41)9-7-8-37-10-12-42-13-11-37;1-17-11-25-22(12-26(17)45-34-19(3)18(2)32(20(4)43-34)44-21(5)38)29-30(37(33(25)40)9-6-8-36-10-7-35-15-36)23-13-27-28(42-16-41-27)14-24(23)31(29)39;1-17-11-22-25(14-26(17)45-34-32(44-21(5)38)19(3)18(2)20(4)43-34)33(40)37(9-6-8-36-10-7-35-15-36)30-23-12-27-28(42-16-41-27)13-24(23)31(39)29(22)30;1-16-9-22-21(10-26(16)44-33-18(3)17(2)31(43-20(5)38)29(45-33)14-40-19(4)37)24-13-35-25-12-28-27(41-15-42-28)11-23(25)30(24)36(32(22)39)8-7-34-6;1-15-9-21-20(10-25(15)41-31-17(3)16(2)29(18(4)39-31)40-19(5)35)23-13-33-24-12-27-26(37-14-38-27)11-22(24)28(23)34(30(21)36)8-7-32-6/h14-17,20-21,27,31-32,34,36H,6-13,18H2,1-5H3;2*7,10-15,18-20,29-30,32,34H,6,8-9,16H2,1-5H3;9-13,17-18,29,31,33-34H,7-8,14-15H2,1-6H3;9-13,16-18,29,31-32H,7-8,14H2,1-6H3/t20-,21+,27-,31?,32?,34-,36+;18-,19-,20-,29?,30?,32?,34-;18-,19+,20-,29?,30?,32-,34-;17-,18-,29-,31?,33-;16-,17-,18-,29?,31-/m10010/s1 |
| InChIKey | BPHZBJNZRWBFSX-UZIWOQRMSA-N |
| XLogP | 22.39 |
| TPSA | 596.49 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 52 |
| Rotatable Bonds | 36 |
| Heavy Atoms | 223 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3061.42 |
| LogP ≤ 5 | 22.39 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 52 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'Polycyclic_aromatic_hydrocarbon_3', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157420242 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.